Investigators accessed longitudinal human data from ebola virus vaccination for signals of efficacy against the Bundibugyo species now surging in the Democratic Republic of Congo.
|Articles|August 22, 2020
FDA Salmonella Recall Investigation: Aldi Peaches
Author(s)Contagion® Editorial Staff
FDA is working with local partners to continue the outbreak investigation.
Advertisement
The US Food and Drug Administration (FDA) is working with local health agencies to investigate an outbreak of Salmonella Enteritidis infections across 9 states.
The outbreak has been tentatively linked to bagged peaches sold at ALDI.
Most people with salmonellosis only develop diarrhea, fever, and abdominal cramps.
In elderly or very immune-suppressed patient populations, however, severe infections can be fatal. In this outbreak, no deaths have been reported.
The FDA updated the status of the investigation in a recent
- The Wawona-brand peaches have been sold in ALDI stores between June 1, 2020 until the present.
- The link to Wawona-brand peaches was established through interviews with those who have fallen ill as well as whole genome sequencing.
- As of mid-August, the US Centers for Disease Control and Prevention (CDC) is reporting a total of 68 cases and 14 hospitalizations across 9 states.
- Consumers, restaurants, and retailers have been advised not to eat, sell, or serve affected products.
- FDA also recommends that those who received the peaches from ALDI clean and sanitize any surfaces that may have come in contact with the produce.
Advertisement
Related to this article
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.